'Oral anticoagulants' presentation slideshows

Reversing New and Existing Anticoagulants: What is the Role of Prothrombin Complex Concentrates in Patient Blood Manag

Reversing New and Existing Anticoagulants: What is the Role of Prothrombin Complex Concentrates in Patient Blood Management?. Presented by: Dr. Lynn Boshkov, MD Prof. Pathology, Medicine & Pediatrics Director Hemostasis & Thrombosis Associate Director Transfusion Medicine

1.2k views • 95 slides

Cardiology

Cardiology. Ventricular Fibrillation/Pulseless Ventricular Tachycardia Algorithm Pharmacology. V. Fib/Pulseless V. Tach. Algorithm is the same for both situations. Determine responsiveness Assess airway, breathing and circulation status Do CPR until monitor is ready

631 views • 60 slides

Zohair Al Aseri. MD, FCEM (UK). FRCPC (EM&CCM).

Pulmonary Emergencies. Zohair Al Aseri. MD, FCEM (UK). FRCPC (EM&CCM). Consultant, Departments of Emergency Medicine & Critical Care. Chairman, Department of Emergency Medicine Director, Master Public Health. King Saud University Hospitals. Riyadh, KSA

745 views • 48 slides

Drugs that affect hemostasis

1.83k views • 42 slides

542 views • 37 slides

TMA DoD Pharmacoeconomic Center Fort Sam Houston, TX

TMA DoD Pharmacoeconomic Center Fort Sam Houston, TX. MTF Quarterly Webcast June 13, 2013. Introduction. Greetings from the PEC Purpose of the Quarterly MTF Webcast DCO Ground Rules Type questions into the DCO system Put on mute, not on hold Contingency plan if DCO system stops working.

475 views • 37 slides

UPDATE ON DIRECT ORAL ANTICOAGULANTS: A PERSPECTIVE BEYOND THE CANCER-VTE GUIDELINES

UPDATE ON DIRECT ORAL ANTICOAGULANTS: A PERSPECTIVE BEYOND THE CANCER-VTE GUIDELINES. Cristhiam M. Rojas-Hernandez, MD Assistant Professor Section of Benign Hematology. Faculty Disclosure. UPDATE ON DIRECT ORAL ANTIACOAGULANTS. OBJECTIVES.

374 views • 37 slides

Seth Scott MD

The New Oral Anticoagulants : Bleeding, Periprocedureal Management, Laboratory Evaluation, and Use for VTE P revention/Treatment. Seth Scott MD. Background. There are 2 approved new oral anticoagulants (NOACs): Dabigatran , and Rivaroxaban

547 views • 36 slides

463 views • 33 slides

VITAMIN E

VITAMIN E. The term vitamin E describes a family of 8 antioxidants, 4 tocopherols ( a , b , g , & d ) and 4 tocotrienols. a -tocopherol is the active form of vitamin E in the human body. FUNCTIONS.

1.89k views • 29 slides

Spotlight Case

Spotlight Case. New Oral Anticoagulants. Source and Credits. This presentation is based on the December 2013 AHRQ WebM&M Spotlight Case See the full article at http://webmm.ahrq.gov CME credit is available

463 views • 24 slides

Spotlight Case

Spotlight Case. New Oral Anticoagulants. Source and Credits. This presentation is based on the December 2013 AHRQ WebM&M Spotlight Case See the full article at http://webmm.ahrq.gov CME credit is available

463 views • 24 slides

Gli anticoagulanti di ultima generazione

409 views • 24 slides

Assessing the Principles of Practice: Stroke Prevention in the New Era of Anticoagulation

Assessing the Principles of Practice: Stroke Prevention in the New Era of Anticoagulation. Use of Stroke or Bleeding Risk Strategies. HAS-BLED. Performance of Bleeding Risk Scores. Which Is True? Select All That Apply. Risk of Intracerebral Hemorrhage Which Is True?.

378 views • 23 slides

Pathogenesis of Antiphospholipid Antibodies in Pregnancy

Pathogenesis of Antiphospholipid Antibodies in Pregnancy. ( 1) Mechanisms on placental cell ( i ) Thrombosis ( a) Aspecific mechanism ( ii) Inflammation ( a) Complement activation ( iii) Immunomodulations ( a) TLR 4 activation by aPL

428 views • 19 slides

Oral anticoagulation

Oral anticoagulation. Illse Louw. Contents. What you should know Cows and rats and creepy crawlies INR Stats. What you should know. Warfarin is an oral anticoagulant It prolongs the time taken for blood to clot This reduces the possibility of clot formation

205 views • 17 slides

HOT LINE PRESENTATION World Congress of Cardiology 2006

Warfarin Antiplatelet Vascular Evaluation - 2161 PAD Patients Dr. Sonia Anand Associate Professor of Medicine McMaster University. HOT LINE PRESENTATION World Congress of Cardiology 2006 Barcelona, Spain September 5, 2006. Rationale. Atherosclerosis is a systemic disease

319 views • 16 slides

Bed rest versus ambulation in the initial treatment of patients with proximal deep vein thrombosis

Bed rest versus ambulation in the initial treatment of patients with proximal deep vein thrombosis. SUMMARY. Treatment for DVTs include low molecular weight heparin (LMWH) and oral anticoagulants In the past, physicians have recommended 4 to 5 days of bed rest for patients with a DVT

255 views • 1 slides

New oral anticoagulants

New oral anticoagulants. TF/VIIa. X. IX. TTP889. IXa. Apixaban Betrixaban Rivaroxaban LY517717 YM150 DU-176b. VIIIa. Va. Xa. II. Dabigatran. IIa. Fibrinogen. Fibrin.

531 views • 1 slides

Figure 1 Simplified schema of the coagulation cascade

Figure 1 Simplified schema of the coagulation cascade. Verheugt, F. W. A. (2010) Novel oral anticoagulants to prevent stroke in atrial fibrillation Nat. Rev. Cardiol. doi:10.1038/nrcardio.2009.235.

247 views • 1 slides